What’s Behind Preterm Birth? Scientists Just Found a Big Clue
Scientists discover how cells in the uterus keep track of pregnancy to ensure an on-time delivery.
Displaying 31 - 60 of 334
-
-
Paxlovid Improved Long COVID Symptoms in Some Patients, Researchers Report
-
How This Cancer Drug Could Make Radiation a Slam Dunk Therapy
UCSF scientists developed a way to deliver radiation just to cancerous cells, rather than attacking both cancerous and healthy tissue. The therapy combines a drug to mark the cancer cells for destruction and a radioactive antibody to kill them.
-
Engineered Immune Cells May Be Able to Tame Inflammation
A new technology uses engineered T cells that act as immune “referees” to soothe overreacting immune responses. They also can mop up inflammatory molecules without lowering the entire body’s immune shields.
-
48 UCSF Researchers Are Honored for Their High-Impact Science
Nearly 50 UCSF researchers have been named to Clarivate’s list of most influential scientists for 2024.
-
What to Know About How Lupus Affects Weight
-
Engineered Receptors Help the Immune System Home in on Cancer
UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer therapies with minimal side effects.
-
How this ‘Switchable’ CAR-T Therapy Sets its Sights on Deadly Brain Cancer
In June, UCSF treated its first patient with E-SYNC, its first homegrown CAR-T therapy, one of the first to show promise in treating certain types of brain cancers. This story builds on previous coverage to provide an overview of CAR-T therapy, accessibility and future horizons of applications in cancer and other illnesses like HIV.
-
How the Keto Diet Could One Day Treat Autoimmune Disorders
A study shows how the keto diet affects the microbiome in ways that may reduce autoimmune responses in the gut.
-
How the Oral Microbiome is Connected to Overall Human Health
Oral health has long been siloed from the rest of a person's health. But increasingly, researchers and clinicians, including those at UCSF, are finding ties between a person's oral health and their overall health.
-
Precision Breast Cancer Trial Shows Improved Treatment by Tumor Subtype
Breast cancer is the second leading cause of cancer deaths in the U.S. and worldwide, pointing to the continuing need to improve treatment strategies and therapies that better patient survival and
-
Is Now the Time for a New COVID-19 Shot?
An extra-long summer surge driven by new variants has prompted the early release of updated COVID-19 vaccines. A UCSF expert tells us what new vaccines could mean for the summer surge, who should get vaccinated, and when/where to get your vaccines.
-
All Your Questions About New Covid Shots, Answered
-
Expert: Here’s What to Know About the MPox Outbreak Emergency
Seth Blumberg, MD, PhD, explains the viral disease mpox, and what the recent emergency declaration from the World Health Organization means for us.
-
Giving an Antibiotic to All Children Under 5 in Africa Saves Lives
A study determines that a life-saving, inexpensive antibiotic, azithromycin, must be given to all children up to 5 years old in Sub-Sharan Africa to realize its full potential.
-
COVID-19 Masks: Expert Tips for What You Should (and Shouldn’t) Do
Face masks remain crucial in preventing the spread of COVID-19, even with vaccine availability. The decision to wear masks depends on vaccination status, risk factors, and local hospitalizations. Medical N95, KN95, or KF94 masks offer the best protection.
-
‘Relentless’ New COVID Variants Extend California’s Summer Wave
-
What to Know About Long COVID and How to Reduce Your Risk
Researchers Micheal Peluso and Valerie Flaherman answer questions about what we know about one of COVID’s most enduring mysteries, including how to potentially reduce your risk and who is most likely to develop long COVID.
-
This May Be the Most Overlooked COVID Symptom
-
‘Visionary’ Study Finds Inflammation, Evidence of COVID Virus Years After Infection
-
Feeling Rough After Your COVID Shot? Congrats, It’s Working!
Adverse symptoms from the COVID-19 vaccine such as chills and headaches are linked to a robust antibody response, indicating increased efficacy compared with recipients who did not experience side effects.
-
Doctors Exploring Possible Link Between COVID and Cancer
-
How Space Research Helps Fight Infection and Aging Back on Earth
Liver samples that spent two months in the International Space Station will be studied to observe how microgravity ages liver cells and impacts their ability to regenerate. Understanding how aging damages the liver – and ways to potentially reverse that damage – could pave the way for better prevention and treatment of liver disease.
-
What to Know about the New Transmissible COVID-19 Variants
-
There’s a New Highly Transmissible COVID-19 Variant. Could FLiRT Lead to a Summer Uptick?
-
Targeted Therapy, Treatment Disparity Featured at Cancer Meeting
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapy, cancer genomics, eliminating treatment disparities and other cancer research topics at this year’s
-
Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms Appear
UCSF scientists have found a set of autoantibodies that emerge in some MS patients years before symptoms.
-
Gene Therapy Is Halting Cancer. Can It Work Against Brain Tumors?
New CAR-T gene therapy techniques could extend survival for patients with glioblastoma.
-
Clusters of Whooping Cough Reported at Private High School in San Francisco
-
Just Ask: Patients in the ER Are Willing to Get a Flu Shot
Intentional flu vaccine messaging, such as a brief video, flyer, or a scripted provider question, is enough to persuade many who visit emergency departments to receive the vaccination.
